No Data
No Data
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Sight Sciences Is Maintained at Buy by Stifel
Sight Sciences Is Maintained at Buy by Stifel
Express News | Stifel Maintains Buy on Sight Sciences, Raises Price Target to $7
Sight Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/08/2024 52.72% Stifel $6 → $7 Maintains Buy 12/04/2023 -12.73% Morgan Stanley $3 → $4 Maintains Equal-W
Q4 2023 Sight Sciences Inc Earnings Call
Sight Sciences (SGHT) Receives a Hold From Piper Sandler
No Data